News

Filter

Current filters:

USANeurological

1 to 9 of 159 results

Lilly licenses pomaglumetad methionil to Denovo as potential schizophrenia therapy

Lilly licenses pomaglumetad methionil to Denovo as potential schizophrenia therapy

03-03-2015

US drug major Eli Lilly has licensed late-stage neuroscience drug pomaglumetad methionil (mGlu2/3 receptor…

Eli LillyLicensingNeurologicalPharmaceuticalpomaglumetad methionilUSA

Actavis receives final FDA approval for generic version of Subutex

Actavis receives final FDA approval for generic version of Subutex

22-02-2015

Ireland-headquartered generics major Actavis has received final approval from the US Food and Drug Administration…

Abbreviated New Drug ApplicationGenericsIndiviorNeurologicalRC PharmaceuticalsReckitt BenckiserRegulationSubutexUSA

UPDATE: FDA approves Eisai’s Lenvima for a type of thyroid cancer and expands use of Banzel

UPDATE: FDA approves Eisai’s Lenvima for a type of thyroid cancer and expands use of Banzel

14-02-2015

The US Food and Drug Administration on Friday granted approval for Japanese pharma major Eisai’s Lenvima…

BanzelEisailenvatinibLenvimaNeurologicalOncologyPharmaceuticalRare diseasesRegulationUSA

Voyager inks up to $845 million deal with Genzyme on novel CNS products

Voyager inks up to $845 million deal with Genzyme on novel CNS products

12-02-2015

US gene therapy start-up company Voyager Therapeutics has entered into a major strategic collaboration…

BiotechnologyGenzymeLicensingNeurologicalResearchSanofiUSAVoyager Therapeutics

Zubsolv market share boosts Orexo valuation, according to Edison research

Zubsolv market share boosts Orexo valuation, according to Edison research

10-02-2015

Swedish drug developer Orexo has laid the foundations to accelerate growth of its Zubsolv (buprenorphine…

FinancialMarkets & MarketingNeurologicalOrexoPharmaceuticalSwedenUSAZubsolv

Anavex confirms positive preclinical data for lead candidate ANAVEX 2-73 in epilepsy

Anavex confirms positive preclinical data for lead candidate ANAVEX 2-73 in epilepsy

10-02-2015

Neurological biopharma company Anavex Life Sciences has confirmed positive preclinical data for lead…

AnavexANAVEX 2-73NeurologicalPharmaceuticalResearchUSA

Shire’s Vyvanse first FDA-approved drug for binge eating

Shire’s Vyvanse first FDA-approved drug for binge eating

31-01-2015

The US Food and Drug Administration on Friday approved UK drugmaker Shire’s Vyvanse (lisdexamfetamine…

NeurologicalPharmaceuticalRegulationShireUSAVyvanse

Supernus sues TWi for infringement of Oxtellar XR patents

22-01-2015

US drugmaker Supernus Pharmaceuticals says that it has sued generic drug makers Taiwan-based TWi Pharmaceuticals…

GenericsLegalNeurologicalOxtellar XRPatentsSupernus PharmaceuticalsTWi PharmaceuticalsUSA

1 to 9 of 159 results

COMPANY SPOTLIGHT

Menarini

Back to top